Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing

Multidrug resistance (MDR) represents a serious global threat due to the rapid global spread and limited antimicrobial options for treatment of difficult-to-treat (DTR) infections sustained by MDR pathogens. Recently, novel β-lactams/β-lactamase inhibitor combinations (βL-βLICs) have been developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaibani, Paolo, Giani, Tommaso, Bovo, Federica, Lombardo, Donatella, Amadesi, Stefano, Lazzarotto, Tiziana, Coppi, Marco, Rossolini, Gian Maria, Ambretti, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137602/
https://www.ncbi.nlm.nih.gov/pubmed/35625273
http://dx.doi.org/10.3390/antibiotics11050628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137602/
https://www.ncbi.nlm.nih.gov/pubmed/35625273
http://dx.doi.org/10.3390/antibiotics11050628

Ejemplares similares